Entera Bio Ltd. (ENTX) NASDAQ
$1.67 0.13 (8.44%)
Market Cap: $54.64M
As of 03/28/24 04:00 PM EDT. Market closed.
Entera Bio Ltd. (ENTX)
NASDAQ
$1.67
0.13 (8.44%)
Market Cap: $54.64M
As of 03/28/24 04:00 PM EDT. Market closed.
Add to Portfolio
entera bio ltd. is a biotechnology company located in ... read more
entera bio ltd. is a biotechnology company located in israel. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Adam Gridley
Full Time Employees
15
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Adam Gridley
Full Time Employees
15
Address
Kiryat Hadassah, Minrav Building, Jerusalem, Fifth Floor, 9112002.
PRICE CHART FOR ENTERA BIO LTD
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.59
Previous Close
$1.54
Days Range
$1.53 - $1.64
52 week range
$0.52 - $1.87
Volume
124,886
Avg. Volume (30 days)
233,846
Market Cap
$54.64M
Dividend Yield
-
P/E
-
Shares Outstanding
35,481,341
Open
$1.59
Previous Close
$1.54
Days Range
$1.53 - $1.64
52 week range
$0.52 - $1.87
Volume
124,886
Avg. Volume (30 days)
233,846
Market Cap
$54.64M
Dividend Yield
-
P/E
-
Shares Outstanding
35,481,341
FINANCIAL STATEMENTS FOR ENTERA BIO LTD
LOADING...
INSIDER TRANSACTIONS FOR ENTERA BIO LTD
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Taitel Haya | Director | Jan 12, 2024 | Buy | $0.99 | 9,500 | 9,405 | 35,115 | Jan 16, 2024, 08:00 AM |
Taitel Haya | Director | Jan 10, 2024 | Buy | $0.77 | 7,615 | 5,864 | 25,615 | Jan 11, 2024, 06:14 PM |
LIEBERMAN GERALD M | Director | Dec 22, 2023 | Buy | $0.71 | 23,952 | 17,006 | 226,961 | Dec 27, 2023, 05:00 PM |
Toledano Miranda Jayne | Chief Executive Officer | Dec 22, 2023 | Buy | $0.71 | 23,952 | 17,006 | 110,752 | Dec 27, 2023, 08:27 AM |
Taitel Haya | Director | Aug 22, 2023 | Buy | $0.62 | 18,000 | 11,216 | 18,000 | Aug 24, 2023, 08:12 AM |
LIEBERMAN GERALD M | Director | Aug 21, 2023 | Buy | $0.59 | 20,000 | 11,784 | 214,209 | Aug 23, 2023, 09:28 AM |
Ellis Sean | Director | Aug 21, 2023 | Buy | $0.60 | 40,000 | 24,000 | 102,100 | Aug 22, 2023, 09:20 AM |
Toledano Miranda Jayne | Chief Executive Officer | Apr 04, 2023 | Buy | $1.01 | 30,000 | 30,300 | 86,800 | Apr 06, 2023, 04:05 PM |
Yaacov-Garbeli Dana | Chief Financial Officer | Nov 14, 2022 | Buy | $0.54 | 26,580 | 14,247 | 56,580 | Nov 15, 2022, 04:13 PM |
Yaacov-Garbeli Dana | Chief Financial Officer | Nov 11, 2022 | Buy | $0.52 | 30,000 | 15,600 | 30,000 | Nov 15, 2022, 04:13 PM |
LIEBERMAN GERALD M | Director | Nov 14, 2022 | Buy | $0.57 | 16,000 | 9,080 | 6,200 | Nov 15, 2022, 04:07 PM |
LIEBERMAN GERALD M | Director | Nov 14, 2022 | Buy | $0.57 | 34,000 | 19,380 | 194,209 | Nov 15, 2022, 04:07 PM |
Ellis Sean | Director | Nov 11, 2022 | Buy | $0.53 | 30,000 | 15,900 | 62,100 | Nov 14, 2022, 09:17 AM |
Toledano Miranda Jayne | Chief Executive Officer | Nov 11, 2022 | Buy | $0.53 | 50,000 | 26,585 | 56,800 | Nov 14, 2022, 09:13 AM |
Ellis Sean | Director | Jul 21, 2022 | Buy | $1.64 | 14,900 | 24,406 | 32,100 | Jul 25, 2022, 05:19 PM |
LIEBERMAN GERALD M | Director | Jul 21, 2022 | Buy | $1.68 | 19,491 | 32,803 | 160,209 | Jul 25, 2022, 05:16 PM |
OSTROV GERALD M | Director | Jan 13, 2022 | Buy | $2.74 | 10,000 | 27,378 | 10,000 | Jan 25, 2022, 08:46 AM |
Ratan Ramesh | U.S.based CFO | Jan 19, 2022 | Buy | $2.44 | 10,000 | 24,364 | 10,000 | Jan 24, 2022, 04:21 PM |
JAMAS SPIROS | Chief Executive Officer | Jan 18, 2022 | Buy | $2.85 | 10,000 | 28,500 | 10,000 | Jan 24, 2022, 04:19 PM |
Schwartz Phillip | President of R&D | Jan 20, 2022 | Buy | $2.53 | 10,000 | 25,250 | 607,410 | Jan 24, 2022, 04:17 PM |
LIEBERMAN GERALD M | Director | Jan 18, 2022 | Buy | $2.80 | 2,800 | 7,840 | 2,200 | Jan 24, 2022, 04:15 PM |
Mayron Ron | Director | Jan 18, 2022 | Buy | $2.80 | 7,000 | 19,600 | 7,000 | Jan 19, 2022, 04:07 PM |
Toledano Miranda Jayne | Director | Jan 14, 2022 | Buy | $2.79 | 6,800 | 18,971 | 6,800 | Jan 19, 2022, 04:04 PM |
Ellis Sean | Director | Jan 18, 2022 | Buy | $2.81 | 10,000 | 28,050 | 10,000 | Jan 19, 2022, 04:02 PM |
Malca Yonatan | Director | Jan 13, 2022 | Buy | $2.74 | 7,232 | 19,816 | 7,232 | Jan 18, 2022, 04:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Taitel Haya | Director | 01/12/2024 | 9,405 |
Taitel Haya | Director | 01/10/2024 | 5,864 |
LIEBERMAN GERALD M | Director | 12/22/2023 | 17,006 |
Toledano Miranda Jayne | Chief Executive Officer | 12/22/2023 | 17,006 |
Taitel Haya | Director | 08/22/2023 | 11,216 |
LIEBERMAN GERALD M | Director | 08/21/2023 | 11,784 |
Ellis Sean | Director | 08/21/2023 | 24,000 |
Toledano Miranda Jayne | Chief Executive Officer | 04/04/2023 | 30,300 |
Yaacov-Garbeli Dana | Chief Financial Officer | 11/14/2022 | 14,247 |
Yaacov-Garbeli Dana | Chief Financial Officer | 11/11/2022 | 15,600 |
LIEBERMAN GERALD M | Director | 11/14/2022 | 9,080 |
LIEBERMAN GERALD M | Director | 11/14/2022 | 19,380 |
Ellis Sean | Director | 11/11/2022 | 15,900 |
Toledano Miranda Jayne | Chief Executive Officer | 11/11/2022 | 26,585 |
Ellis Sean | Director | 07/21/2022 | 24,406 |
LIEBERMAN GERALD M | Director | 07/21/2022 | 32,803 |
OSTROV GERALD M | Director | 01/13/2022 | 27,378 |
Ratan Ramesh | U.S.based CFO | 01/19/2022 | 24,364 |
JAMAS SPIROS | Chief Executive Officer | 01/18/2022 | 28,500 |
Schwartz Phillip | President of R&D | 01/20/2022 | 25,250 |
LIEBERMAN GERALD M | Director | 01/18/2022 | 7,840 |
Mayron Ron | Director | 01/18/2022 | 19,600 |
Toledano Miranda Jayne | Director | 01/14/2022 | 18,971 |
Ellis Sean | Director | 01/18/2022 | 28,050 |
Malca Yonatan | Director | 01/13/2022 | 19,816 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ENTERA BIO LTD
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 57,400 | 0.00005% | 145.3% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 17,597 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR ENTERA BIO LTD
STOCK BUYBACKS FOR ENTERA BIO LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
2.71%
1Q
06/30/2023
2.72%
2Q
03/31/2023
2.72%
3Q
12/31/2022
2.72%
4Q
09/30/2022
2.72%
5Q
06/30/2022
2.73%
6Q
03/31/2022
2.74%
7Q
12/31/2021
2.31%
8Q
09/30/2021
3.19%
9Q
06/30/2021
19.74%
10Q
03/31/2021
35.20%
11Q
12/31/2020
55.32%
12Q
09/30/2020
61.46%
13Q
06/30/2020
62.30%
14Q
03/31/2020
63.97%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ENTERA BIO LTD
LOADING...